Meeting Reports (Ethics)Journal of Pharmacology and PharmacotherapeuticsVol. 11 | Issue 4 | 2021 | pp. 154–156Open access
Scenarios in Medical Ethics-5: Informed Consent Process
- 1*,
- 2,
- 1,
- 1
- 1 Department of Pharmacology, JIPMER, Puducherry, India.
- 2 Department of Paediatrics and Critical Care, JIPMER, Puducherry, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Jayanthi Mathaiyan
Department of Pharmacology, JIPMER, Puducherry, India.
Email: drjayanthi2008@gmail.com
Copyright: © 2021 Manuscript Technomedia LLP. This is an open access article.
- Published:
- May 14, 2021
- Received:
- Dec 24, 2020
- Accepted:
- Dec 29, 2020
How to cite
Mathaiyan, J., Parameswaran, N., Natarajan, H., & Raveendran, R. (2021). Scenarios in Medical Ethics-5: Informed Consent Process. Journal of Pharmacology and Pharmacotherapeutics, 11(4), 154–156. https://doi.org/10.4103/jpp.jpp_175_20
Abstract
Informed consent process is becoming more challenging these days with researchers involved in collecting data during complex situations like an emergency or an epidemic. Other concerns are about translating into local language of informed consent documents prepared in English and consent for reuse of stored samples to obtain additional information, to name a few. To address some of these issues, a 1-h panel discussion session on “Informed consent process” was held during the 2-day workshop organized for Institutional Ethics Committee (IEC) members on September16–17, 2019, at Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, in association with Indian Council of Medical Research Bioethics unit, Bangalore. We planned each session to have a lecture followed by case discussions. Each session included a series of 3–6 scenarios followed by 1–3 questions. After presenting each scenario, the participants were invited to give their comments. After a thorough discussion, a set of panelists, who were experts in biomedical ethics, were invited to discuss the scenario and provide more informed and authoritative opinions. The discussions were quite lively, and we believe that the case scenarios should be of wider interest. Four similar panel discussion sessions on other topics have already been published in earlier issues of this journal. In this article, we discuss the session on “Informed consent process.” The answers provided by the participants are listed first followed by the expert opinion by the panelists.
Subject
Article metadata
| Title | Scenarios in Medical Ethics-5: Informed Consent Process |
|---|---|
| Authors | Jayanthi Mathaiyan; Narayanan Parameswaran; Harivenkatesh Natarajan; R. Raveendran |
| Affiliations | Department of Pharmacology, JIPMER, Puducherry, India.; Department of Paediatrics and Critical Care, JIPMER, Puducherry, India. |
| Corresponding author | drjayanthi2008@gmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 11, Issue 4 (2021) |
Also in this issue
- Adaptive Designs in Clinical Trialspp. 129–133
- Comparison of Topical Ivermectin and Oral Ivermectin in the Treatment of Human Scabies: A Randomized Controlled Trialpp. 134–139
- Late-Onset Clozapine-Induced Agranulocytosis in a Young Woman with Paranoid Schizophreniapp. 140–141
- Scenarios in Medical Ethics-1: Composition and Functioning of Ethics Committeespp. 142–144
- Scenarios in Medical Ethics 2: Challenges for Ethics Committeespp. 145–147
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026